CASI Pharmaceuticals, Inc (DE)

MARSHALL WACE, LLP

Report date

12/31/2021

Quarter

2021 Q4

Filed

2/14/2022

Shares

300,508

Value ($000)

241

Weight

0.0%

2021 Q2 - 2021 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q4	2/14/2022	241	0.0%	300,508	12/31/2021
2021 Q3	11/15/2021	1,133	0.0%	952,037	9/30/2021
2021 Q2	8/13/2021	347	0.0%	223,709	6/30/2021